WHC is still in active development. Read this to understand our approach.
depiction of CKHJPWQVLKHBIH-UHFFFAOYSA-N.svg
tripsit

sulbutiamine

Check on tripsit

isomerdesign

Sulbutiamine

Check on isomerdesign

wiki

Sulbutiamine

Check on wiki

Data

InChI: InChI=1S/C32H46N8O6S2/c1-19(2)31(43)45-11-9-27(21(5)39(17-41)15-25-13-35-23(7)37-29(25)33)47-48-28(10-12-46-32(44)20(3)4)22(6)40(18-42)16-26-14-36-24(8)38-30(26)34/h13-14,17-20H,9-12,15-16H2,1-8H3,(H2,33,35,37)(H2,34,36,38)

Synonyms: DTXCID3026641,Sulbutiamine,AKOS015965079,bisibutiamine,Vitaberin,SCHEMBL25578,[5-[(4-amino-2-methyl-pyrimidine-5-carbonyl)-methyl-amino]-3-[1-[(4-amino-2-methyl-pyrimidine-5-carbonyl)-methyl-amino]ethylidene]-4-[2-(2-methylpropanoyloxy)ethyl]-6,6-bis(sulfanyl)hex-4-enyl] 2-methylpropanoate;Sulbutiamine,sulbut,arcalion,Sulbutiamine (INN),3286-46-2,Youvitan,Tox21_112460_1,youvitan,BCP9000417,[(Z)-4-[(4-Amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-[[(E)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-(2-methylpropanoyloxy)pent-2-en-3-yl]disulfanyl]pent-3-enyl] 2-methylpropanoate,MFCD01726427,A821472,isobutyryl thiamine disulfide,ZINC150338505,HMS3886G15,Youvitan (TN),HY-B2229,D01319,AMY30241,Disulfanediylbis(4-(N-((4-amino-2-methylpyrimidin-5-yl)methyl)formamido)pent-3-ene-3,1-diyl) bis(2-methylpropanoate),Q-201756,enerion,s5203,NCGC00167456-02,CCG-270389,[(Z)-4-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-formyl-amino]-3-[[(Z)-2-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-formyl-amino]-1-[2-(2-methylpropanoyloxy)ethyl]prop-1-enyl]disulfanyl]pent-3-enyl] 2-methylpropanoate,Tox21_112460,CAS-3286-46-2,BCP05328,DTXSID5046641,[(Z)-4-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-[[(Z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-(2-methylpropanoyloxy)pent-2-en-3-yl]disulfanyl]pent-3-enyl] 2-methylpropanoate,CHEMBL2105813,NCGC00167456-01,Bisibuthiamine (JAN),Bisibuthiamine,bisibuthiamine,CS-7920

Market name: sulbutiamine

Estimated data

Solubility: -6.164 (log(S) in mol/L prediction using SolTranNet)

Addictivity Prediction: 34.8% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.